Kitang, Liam Kurt S.

HRN: 22-65-16  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/04/2023
CEFTRIAXONE 1G (VIAL)
10/04/2023
10/10/2023
IVT
900mg
Od
Pcap C
Waiting Final Action 
10/09/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/09/2023
10/15/2023
IV
140mg
OD
PCAP-C
Waiting Final Action 
10/11/2023
MUPIROCIN 2%, 15G (TUBE)
10/11/2023
10/17/2023
TOPICAL
2%
BID
Rashes
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: